Celgene Expands Relationship with Medidata in Enterprise Clinical Trial Technology

NEW YORK–(BUSINESS WIRE)–Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Celgene Corporation has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform for all clinical trials worldwide. To drive therapeutic excellence in the interest of patients through a sustainable pipeline of cancer and inflammatory disease treatments, C
Source: BusinessWire-Primary

Celgene Expands Relationship with Medidata in Enterprise Clinical Trial Technology